Phase II study of axitinib for downstaging cT2a to cT1 renal tumors for allowing partial nephrectomy (AXIPAN). - Université de Rennes Access content directly
Journal Articles Journal of Clinical Oncology Year : 2016

Phase II study of axitinib for downstaging cT2a to cT1 renal tumors for allowing partial nephrectomy (AXIPAN).

Abstract

no abstract

Domains

Bioengineering
No file

Dates and versions

hal-01361499 , version 1 (07-09-2016)

Identifiers

  • HAL Id : hal-01361499 , version 1

Cite

Jean-Jacques Patard, Jean-Christophe Bernard, Karim Bensalah, Hervé Baumert, Hervé Lang, et al.. Phase II study of axitinib for downstaging cT2a to cT1 renal tumors for allowing partial nephrectomy (AXIPAN).. Journal of Clinical Oncology, 2016, 34 (2). ⟨hal-01361499⟩
128 View
0 Download

Share

Gmail Facebook X LinkedIn More